МЕДИЦИНСКОЕ УЧРЕЖДЕНИЕ "КЛИНИКА АГЕС"
This is a company preview
Unlock the full report for 1 check — contacts, bank accounts, court cases, government contracts, arrests, licenses and PDF export.
Summary
Министерство юстиции РКActivities
1ОКЭДОбщая врачебная практика
Contacts
Change history
Financial statements
PremiumPublic contracts
Assets
Bank accounts
Leadership
1- АД
Алпыспаева Дамегуль Тулеухановна
Director
since 18.05.1999
Founders
Accreditations
Employees
Affiliated companies
PremiumDirector's involvement in other legal entities
Branches
Risks
1/17Комитет государственных доходов · Государственные закупки РК · АО ФНБ «Самрук-Казына» · АОО «НИШ»Found in government registries against the company’s director or founders. They do not affect the company’s own reliability score.
- DirectorАЛПЫСПАЕВА ДАМЕГУЛЬ ТУЛЕУХАНОВНАNot present at its registered address
This assessment is informational and analytical only, based on our internal methodology and open sources; it is not an official government conclusion or a guarantee of reliability.
Court cases
Arrests & encumbrances
Enforcement proceedings
Certificates
Licenses
Company networks
PremiumSimilar companies
Media mentions
Company summary
МЕДИЦИНСКОЕ УЧРЕЖДЕНИЕ "КЛИНИКА АГЕС" (BIN 990540005388) is an active legal entity in Павлодарская область, registered in 1999 (27 years on the market). Primary activity — общая врачебная практика. Automated screening found 2 risk indicators for "КЛИНИКА АГЕС". Director on record — Алпыспаева Дамегуль Тулеухановна. Data current as of October 1, 2026.
Information is aggregated from open government registries of Kazakhstan: Министерство юстиции РК, Комитет государственных доходов МФ РК, Верховный Суд РК, Портал государственных закупок РК, АО «Самрук-Казына», Бюро национальной статистики РК, Портал электронного лицензирования. Data is indexed automatically and may lag behind primary sources; the absence of a record does not guarantee the absence of the corresponding facts. This is reference information and does not replace an official extract. Learn more about the methodology and sources — SafeDeal editorial policy.